We (current shareholders) should go after both FDA- to reinstate Anchor/compromise on V label and Amarin's Board to seek partnerships. This is the only way for us to prevent otherwise inevitable dilution.
The best way to end this....go to a Carl Icahn type investor and encourage them to buy 9.8% of the company. Give them a board seat, copies of all your info with the FDA and let the hedgefund take on the FDA. They are the one's who can get the attention of congress. For less than $20 million investment, the fund can turn that into almost a half million dollar profit and probably do so in less than a year.